Marked increase in proton pump inhibitors use in Australia

Pharmacoepidemiology and Drug Safety
Samantha HollingworthJennifer H Martin

Abstract

To examine the trends in the prescribing of subsidized proton pump inhibitors (PPIs) and histamine receptor antagonists (H2RAs), in the Australian population from 1995 to 2006 to encourage discussion regarding appropriate clinical use. PPIs and H2RAs are the second highest drug cost to the publicly subsidized Pharmaceutical Benefits Scheme (PBS). Government data on numbers of subsidized scripts, quantity and doses for PPIs and H2RAs were analysed by gender and age, dose and indication. Drug utilisation as DDD [defined daily dose]/1000 population/day. The use of combined PPIs increased by 1318%. Utilisation increased substantially after the relaxation of the subsidized indications for PPIs in 2001. Omeprazole had the largest market share but was substituted by its S-enantiomer esomeprazole after its introduction in 2002. There was considerable use in the elderly with the peak use being in those aged 80 years and over. The utilisation of H2RAs declined 72% over 12 years. PPI use has increased substantially, not only due to substitution of H2RAs but to expansion in the overall market. Utilisation does not appear to be commensurate with prevalence of gastro-oesophageal reflux disease (GORD) nor with prescribing guidelines for PPIs,...Continue Reading

References

Jul 1, 1988·Baillière's Clinical Gastroenterology·H F Helander
Oct 10, 1997·The Medical Journal of Australia·H G PeachS J Farish
Mar 28, 1998·The American Journal of Gastroenterology·P SharmaR E Sampliner
Dec 23, 1998·Journal of Quality in Clinical Practice·P BoltonM M Lahra
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·M NauntonM D Bleasel
Feb 13, 2001·BMJ : British Medical Journal·J A Sterne, G Davey Smith
Apr 20, 2004·The Medical Journal of Australia·Lybus C HillmanAnthony C Clarke
Jul 28, 2004·Archives of Internal Medicine·John T Chang, David A Katzka
Feb 1, 2005·Alimentary Pharmacology & Therapeutics·R FossmarkH L Waldum
Mar 8, 2005·The Medical Journal of Australia·Nimeshan GeevasingaPatrick L Coleman
Oct 27, 2006·The New England Journal of Medicine·Martin EpsteinFlorence Law
Oct 27, 2006·Pharmacy World & Science : PWS·Teerapon Dhippayom, Roger Walker
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Yu-Xiao YangDavid C Metz
Mar 21, 2007·Archives of Surgery·Amy L FriedmanRichard N Formica
Jun 16, 2007·European Heart Journal·Jean-Pierre BassandWilliam Wijns
Jun 21, 2007·British Medical Bulletin·Kathrin M CresswellAziz Sheikh
Aug 28, 2007·Journal of Medical Case Reports·Kouichi Nobata, Hidetsugu Asanoi
Jan 5, 2008·BMJ : British Medical Journal·Ian Forgacs, Aathavan Loganayagam
Mar 4, 2008·Bone·René RizzoliJean-Yves Reginster
Jul 22, 2008·The Medical Journal of Australia·Stephanie A KnoxJoan V Henderson
Dec 30, 2008·Pharmacoepidemiology and Drug Safety·Gregory J KyleSusan E Tett
Jan 24, 2009·The New England Journal of Medicine·Jane E Freedman, Elaine M Hylek
Feb 11, 2009·The Medical Journal of Australia·Nicholas J Talley
Feb 11, 2009·The Medical Journal of Australia·Elizabeth E RougheadAndrew L Gilbert
Mar 5, 2009·JAMA : the Journal of the American Medical Association·P Michael HoJohn S Rumsfeld
Mar 10, 2009·Lancet·Nicholas J Shaheen, Joel E Richter
Apr 1, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·F de VriesC Cooper
Apr 2, 2009·The American Journal of Gastroenterology·Jasmohan S BajajKia Saeian
May 16, 2009·Drug Discovery Today·James M MullinJames J Thornton

❮ Previous
Next ❯

Citations

Feb 13, 2013·Journal of General Internal Medicine·Andrew J GawronSherri L Lavela
Nov 20, 2012·Australian Health Review : a Publication of the Australian Hospital Association·Anna KempElizabeth E Roughead
Feb 19, 2013·PloS One·Stephen R Rotman, Tara F Bishop
Nov 25, 2011·Paediatric Drugs·Matthew W Carroll, Kevan Jacobson
Apr 9, 2014·BMC Health Services Research·Suvimol NiyomnaithamAlesha J Smith
Mar 1, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Andrew J GawronJohn E Pandolfino
Jul 26, 2011·Homeopathy : the Journal of the Faculty of Homeopathy·Marcus Zulian Teixeira
Apr 2, 2016·Research in Social & Administrative Pharmacy : RSAP·Pratik P RaneRajender R Aparasu
Dec 13, 2012·Pharmacoepidemiology and Drug Safety·Hojjat SalmasianCarol Friedman
Mar 20, 2013·Geriatrics & Gerontology International·Anna Amrit Jarchow-Macdonald, Arduino A Mangoni
Aug 3, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Anita TrikhaRana S Bonds
Apr 6, 2013·Pharmacoepidemiology and Drug Safety·Susan E TettNadia Barozzi
Jun 15, 2011·Pharmacoepidemiology and Drug Safety·Martin WawruchMagdalena Kuzelova
Mar 31, 2016·Health Economics Review·A ConwayLenihanN Woods
Apr 2, 2015·Internal Medicine Journal·P S Nishtala, L Soo
Oct 25, 2014·European Archives of Psychiatry and Clinical Neuroscience·Britta HaenischMartin Scherer
Jun 4, 2016·Pharmacoepidemiology and Drug Safety·Fatmah OthmanColin J Crooks
Dec 7, 2016·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Nicole L PrattElizabeth E Roughead
Jan 28, 2017·Journal of Gastroenterology and Hepatology·Riley BatchelorDanny Liew
Jul 24, 2018·Expert Opinion on Drug Safety·Edoardo SavarinoVincenzo Savarino
Oct 26, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rianne A WeersinkSander D Borgsteede
Mar 13, 2019·Clinical Pharmacology and Therapeutics·Shih-Tsung HuangFei-Yuan Hsiao
Nov 7, 2019·International Journal of Molecular Sciences·Holmfridur Helgadottir, Einar S Bjornsson
Jul 25, 2019·Journal of Gastroenterology and Hepatology·Salman HussainAbul Kalam Najmi
Jan 28, 2014·Journal of Pediatric Gastroenterology and Nutrition·Pauline De BruyneMyriam Van Winckel
Feb 29, 2020·Digestive Diseases and Sciences·Magdalena Gómez-MateosAdela Valero
Jun 2, 2020·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Madhav DesaiPrateek Sharma
Sep 30, 2016·The Medical Journal of Australia·David J Gracie, Alexander C Ford
Jul 1, 2017·Clinical Journal of Gastroenterology·Tsutomu TakedaSumio Watanabe
Sep 13, 2017·Journal of Clinical Pharmacy and Therapeutics·M NauntonS Kosari
Nov 20, 2019·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·David S RoseJoseph C Lee
Mar 29, 2020·Therapeutic Advances in Gastroenterology·Benjamin DanielsHelga Zoega
Apr 20, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Gulistan BahatMehmet Akif Karan
Dec 12, 2019·European Journal of Clinical Pharmacology·Su-Yeon YuSamantha A Hollingworth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Geriatric Pharmacotherapy
Claudene J GeorgeJoseph S Ross
Journal of Clinical Pharmacy and Therapeutics
M NauntonM D Bleasel
European Journal of Internal Medicine
George NtaiosDimitrios Karamitsos
JAMA : the Journal of the American Medical Association
Shoshana J HerzigEdward R Marcantonio
© 2021 Meta ULC. All rights reserved